Matteo Foschi Presents The New Expert Guidance on Minor Ischemic Stroke
Matteo Foschi, Neurologist at Azienda USL della Romagna, shared on LinkedIn:
”Thrilled to share our new Expert Guidance on the acute management of minor ischemic stroke!
Honored to have co-led this work with an outstanding international team of stroke leaders, now published in Stroke (American Heart Association).
Federico De Santis, Lucio D’Anna, Urs Fischer, Else Charlotte Sandset, Thanh Nguyen, Ahmed Nasreldein, Octavio Marques Pontes-Neto, Tsivgoulis Georgios, Pooja Khatri, Shelagh Coutts, Guillaume Turc, Simona Sacco
Minor ischemic strokes may appear “mild,” but up to 30% of patients develop disability within 90 days — a reminder that minor does not mean benign.
Our guidance provides a pragmatic, scenario-based framework to support clinicians in navigating some of the most controversial areas in acute stroke care:
- Disabling vs nondisabling minor stroke
- Role of IV thrombolysis and dual antiplatelet therapy
- Early anticoagulation in cardioembolic minor stroke
- When (and whether) to perform thrombectomy in low NIHSS with LVO
- Managing rapidly improving symptoms
- Post-reperfusion antithrombotic strategies
- Considerations for low-resource settings
This document aims to translate complex evidence into clear, actionable decision pathways, highlighting where we do have robust data — and where future trials are urgently needed.
A huge thank you to all coauthors and collaborators worldwide for their expertise, energy, and commitment
Open access article available now.
Proud to contribute to improving global stroke care and to stimulate the next generation of research in this challenging field.”
Read the full article here.
Article: Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians
Authors: Federico De Santis, Matteo Foschi, Pooja Khatri, Ahmed Nasreldein, Else Charlotte Sandset, Georgios Tsivgoulis, Lucio D’Anna,Shelagh Coutts, Urs Fischer, Octávio Pontes-Neto, Thanh Nguyen, Guillaume Turc, Simona Sacco

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke